Molecular biologist Professor Doug Hilton has been appointed to lead the national science agency, replacing Dr Larry Marshall who completes his term as CEO this month.

Professor Hilton is director of the Walter and Eliza Hall Institute of Medical Research (WEHI) and head of medical biology at the University of Melbourne.

As WEHI director, Professor Hilton and his team, who hold more than 20 patents, have collaborated with venture capitalists and the biopharmaceutical industry in the fields of cancer, infectious and immune diseases, developmental disorders and diseases of ageing.

He is also an advocate for the representation of women in senior roles in the medical research sector.

CSIRO Chair Kathryn Fagg said said Professor Hilton was a greatly respected researcher, leader and science communicator who will be a great asset to the organisation.

“Beyond research, Doug has emphasised the importance of strong institutional cultures, and furthered diversity in science,” she said.

Professor Hilton said he looked forward to taking up the post.

“The intent of CSIRO and my personal values are completely aligned, and I am looking forward to leading CSIRO as we work to solve our nation’s greatest challenges,” he said in a statement.

Professor Hilton begins in his new role in September, with Kirsten Rose, CSIRO’s Executive Director Future Industries, to act as Chief Executive from 1 July.